Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

High-throughput screening in primary neurons.

Punita Sharma1, D Michael Ando, Aaron Daub

  • 1Gladstone Institute of Neurological Disease, San Francisco, California, USA.

Methods in Enzymology
|February 21, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A three-groups non-local model for combining heterogeneous data sources to identify genes associated with Parkinson's disease.

Biometrics·2026
Same author

Predictive Cellular Signatures from Live Human Motor Neurons Distinguish TDP-43 ALS and Enable ALS Subtype Stratification.

bioRxiv : the preprint server for biology·2026
Same author

Survey of the human proteostasis network: the ubiquitin-proteasome system.

bioRxiv : the preprint server for biology·2026
Same author

Neurogenin-2 Reprograms Human Microglial Lineage Cells into Neurons In Vitro and in Chimeric Brains.

bioRxiv : the preprint server for biology·2026
Same author

Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survival.

medRxiv : the preprint server for health sciences·2026
Same author

A myeloid trisomy 21-associated gene variant is protective from Alzheimer's disease.

Nature neuroscience·2025
Same journal

1,2-Aminothiol-specific conjugation for dual-color fluorescent labeling via ultrafast TAMM conjugates.

Methods in enzymology·2026
Same journal

Nitrone dipoles in bioorthogonal chemistry applications.

Methods in enzymology·2026
Same journal

Bioorthogonal labeling of sialic acid isomers for detection of glycoconjugates by mass spectrometry imaging and microscopy.

Methods in enzymology·2026
Same journal

Bioorthogonal photocatalytic proximity labeling for quantitative mapping of cell-cell interactions.

Methods in enzymology·2026
Same journal

inCu-click: Enabling copper-catalyzed click chemistry inside living cells.

Methods in enzymology·2026
Same journal

Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling.

Methods in enzymology·2026
See all related articles

Developing novel therapeutics for neurodegenerative diseases like Alzheimer's and Parkinson's requires advanced screening. Our high-throughput screening (HTS) in primary neurons offers a biologically relevant approach to accelerate drug discovery.

Area of Science:

  • Neuroscience
  • Drug Discovery
  • Cell Biology

Background:

  • Neurodegenerative diseases like Alzheimer's, Parkinson's, Huntington's, and ALS lack disease-modifying treatments.
  • Current drug discovery methods face limitations in generating physiologically relevant data, hindering therapeutic development.

Purpose of the Study:

  • To introduce a high-throughput screening (HTS) system utilizing primary neurons to identify potential therapeutics for neurodegenerative diseases.
  • To enhance the biological relevance of screening by employing fully differentiated neurons.

Main Methods:

  • Detailed methodologies for a primary neuron HTS assay workflow, from sample preparation to data reporting.
  • Adaptation of the HTS system into high-content screening (HCS) for in situ analysis of cellular events using fluorescence imaging.

More Related Videos

Preparation of Neuronal Co-cultures with Single Cell Precision
09:06

Preparation of Neuronal Co-cultures with Single Cell Precision

Published on: May 20, 2014

Related Experiment Videos

Last Updated: May 24, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Preparation of Neuronal Co-cultures with Single Cell Precision
09:06

Preparation of Neuronal Co-cultures with Single Cell Precision

Published on: May 20, 2014

Main Results:

  • The HTS system enables rapid assaying of thousands of conditions, potentially revealing new biological insights.
  • Primary neuron HTS captures critical cellular events relevant to neuronal susceptibility in disease states.

Conclusions:

  • HTS in primary neurons provides a powerful and biologically relevant platform to accelerate the discovery of therapeutics for neurodegenerative diseases.
  • High-content screening (HCS) adaptation is suitable for studying dynamic processes in living cells.